Company Profile Company Management
i2c Pharmaceutical Services is the trading name for Cardiff Scintigraphics Limited, a spin-off company from Cardiff University.

Current sponsors of RDD online web based training module Aerosol Deposition and Assessment of Pulmonary Drug Delivery” by Dr Stephen P. Newman.

i2c was established in 1992 by scientists within the School of Pharmacy and Pharmaceutical Sciences following several years of successfully conducting clinical gamma scintigraphy studies for the pharmaceutical industry. The founding scientific directors were Glyn Taylor, Stephen Farr and Ian Kellaway.

i2c has built a wealth of knowledge in the area of drug formulation and device development and research. i2c has a fourteen year history as an independent company, meeting the diverse objectives and exacting standards of pharmaceutical development.

i2c provides independent services to clients for development of pharmaceutical formulations and devices within laboratories at Cardiff. An alliance between i2c and Simbec Research Limited has existed since the mid-1990's and via this collaboration, human scintigraphy studies are conducted within the clinical pharmacology unit at Simbec.

i2c has a dedicated team specializing in the niche services described on this site and endeavours to provide an efficient, reliable and effective service.

 

Professor Glyn Taylor
Director of Research
Email: glyn@i2cpharm.co.uk
Phone: +44 (0)29 2075 7865



Dr Simon warren
Research Manager
Email: simon.warren@i2cpharm.co.uk
Phone: +44 (0)29 2075 7865